p21ras is modified by a farnesyl isoprenoid

Proc Natl Acad Sci U S A. 1989 Nov;86(21):8323-7. doi: 10.1073/pnas.86.21.8323.

Abstract

Association of oncogenic ras proteins with cellular membranes appears to be a crucial step in transformation, ras is synthesized as a cytosolic precursor, which is processed to a mature form that localizes to the plasma membrane. This processing involves, in part, a conserved sequence, Cys-Ali-Ali-Xaa (in which Ali is an amino acid with an aliphatic side chain and Xaa is any amino acid), at the COOH terminus of ras proteins. Yeast a-factor mating hormone precursor also possesses a COOH-terminal Cys-Ali-Ali-Xaa sequence. However, while the COOH-terminal cysteine has been implicated as a site of palmitoylation of ras proteins, in mature a-type mating factor this residue is modified by an isoprenoid, a farnesyl moiety. We asked whether the Cys-Ali-Ali-Xaa sequence signaled different modifications for the yeast peptides (farnesylation) than for ras proteins (palmitoylation) or whether ras proteins were similar to the mating factors and contained a previously undiscovered isoprenoid. We report here that the processing of ras proteins involves addition of a farnesyl moiety, apparently at the COOH-terminal cysteine analogous to the cysteine modified in the yeast peptides, and that farnesylation may be important for membrane association and transforming activity of ras proteins.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Cells, Cultured
  • Farnesol / metabolism*
  • Genes, ras*
  • Mevalonic Acid / metabolism*
  • Mice
  • Molecular Sequence Data
  • Oncogene Protein p21(ras) / genetics
  • Oncogene Protein p21(ras) / isolation & purification
  • Oncogene Protein p21(ras) / metabolism*
  • Transfection

Substances

  • Farnesol
  • mevalonolactone
  • Oncogene Protein p21(ras)
  • Mevalonic Acid